This Solicitation opportunity from Government of Canada was posted on January 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pralidoxime

Closed

W6369-26-A033International

Submission Closed01/22/2026, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

Solicitation # SPE2DP-26-T-4957

This contract is for the procurement of Benzonatate Capsules, USP, 100 mg, provided in bottles of 100 units. The items must be stored at a controlled room temperature between 20 and 25 degrees Celsius and protected from light, moisture, and humidity. The order consists of two bottles under NSN 6505006601798, with a non-extendable shelf life of 36 months. The agreement specifies a delivery timeframe of 20 days after receipt of the order, with FOB destination for both inspection and acceptance. Compliance with FDA regulations, DLA packaging requirements, and Medical Marking Standard No. 1 is mandatory. The solicitation is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under contract number SPE2DP-26-T-4957.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4955

This contract, identified as SPE2DP-26-T-4955, is for the procurement of Famotidine Tablets, 20 mg, in unit dose packages of 100 tablets. The requirement includes two line items with a total quantity of 15 packages, delivered FOB destination to locations in Baumholder, Germany. The drug is FDA regulated and must adhere to a non-extendable shelf-life requirement of 30 months. Compliance with DLA packaging and marking standards is mandatory, specifically Medical Marking Standard No. 1 and RP001 for palletization. All items must be secured in sealed unit containers and commercial exterior shipping containers to prevent damage. Delivery is required within 10 days, with required delivery dates set for September 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4951

This contract, identified as SPE2DP-26-T-4951, is for the procurement of Isoniazid Tablets USP, 300 mg, supplied in bottles of 100. The drug is FDA regulated and requires storage at medical controlled room temperature. The agreement specifies a non-extendable shelf life of 36 months and mandates compliance with the latest Medical Marking Standard No. 1 and DLA packaging requirements. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. The order consists of three line items totaling nine bottles, distributed across three different vessels: the USS Kidd, USS Roosevelt, and USS Canberra. Delivery is required within 20 days, with required delivery dates set for September 2026. Shipping is designated as FOB Destination, and the contractor must adhere to specific marking and labeling standards, including MIL-STD-129 and ASTM D3951 for non-hazardous materials.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-26-T-4856

This contract is for the procurement of Povidone-Iodine Cleansing Solution, USP 7.5%, supplied in one-gallon bottles. The product is regulated by the FDA and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. A critical requirement is the shelf life, which is 36 months total, with at least 31 months remaining at the time of delivery to the first government activity. The agreement includes three separate line items totaling 13 bottles to be delivered to the USNS Billy Frank Jr, USS Ashland, and USS Springfield. Delivery is required within five days, and the shipping terms are FOB Destination. Suppliers must comply with DLA packaging and marking standards, including Medical Marking Standard No. 1, and must provide Safety Data Sheets and hazardous communication labels in accordance with OSHA and Federal Standard No. 313-E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-4794

Solicitation SPE2DP-26-T-4794 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of activated suspension charcoal, identified by NSN 6505-01-282-8880. The requirement consists of three line items totaling 57 bottles, with each bottle containing 240 ml and 50 grams of material. Delivery is required within 20 days after receipt of order, with a target delivery date of September 2, 2026. Shipments are designated as FOB Destination, with delivery locations including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address in AP. The product must have a shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Storage must be maintained at 20 to 25 degrees Celsius. Packaging must comply with DLA Packaging Requirements for Procurement RP001 and ASTM D3951, unless the material is deemed hazardous per FED-STD-313, in which case TQ requirement IP025 applies. Labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. All materials must be marked according to Medical Marking Standard No. 1. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The procurement is subject to various federal regulations, including the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity assessment requirements. Quotations are due by September 8, 2026, and must be submitted to the DLA Troop Support office in Philadelphia, Pennsylvania.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-415G

This contract is for the procurement of medical test strips and color charts used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobiligen in urine. The items are issued in bottles containing 100 strips each, with a total quantity of two bottles requested under solicitation SPE2DS-26-T-415G. Delivery is required within 20 days after receipt of the order. The supplies must adhere to strict quality and packaging standards, including Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 18 months applies, with a mandate that no more than two months may have elapsed from the date of manufacture to the date of delivery. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

LEVONORGESTREL AND ETH

Solicitation # SPE2DP-26-T-4956

This contract is for the procurement of Levonorgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription medication. Each unit of issue consists of one package containing 168 tablets, organized into six cycles of 28 tablets each. Each cycle follows a specific sequence of varying dosages of Levonorgestrel and Ethinyl Estradiol, concluding with seven tablets of inert ingredients. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius. The tablets have a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Packaging and marking must strictly adhere to Medical Marking Standard No. 1A and DLA packaging requirements to ensure the protection of contents during transit. Delivery is set for 20 days after the order, with the inspection and acceptance point designated as the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORGESTREL AND ETHINYL

Solicitation # SPE2DP-26-T-4961

This contract is for the procurement of Norgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription drug for oral administration. Each unit of issue consists of a package containing six blister card dispensers, with each card holding 21 active tablets (0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol) and 7 inactive tablets, totaling 168 tablets per package. The product has a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Storage must be maintained at controlled room temperature between 20 and 25 degrees Celsius. The agreement specifies strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements to ensure the protection of contents from damage during transit. It explicitly prohibits the intentional addition of mercury or mercury-containing compounds. Delivery is set for destination, with a required delivery date of September 10, 2026, and a delivery window of 20 days. The contract is managed by the Department of Defense Medical Supply Chain Pharmacy FSA, with shipping destined for Prince Sultan Air Base in Saudi Arabia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4966

This contract is for the procurement of Dextrose Oral Gel, provided in 15 gram squeeze tubes with twist-off tips and packaged in sets of three. The product is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. The procurement includes two separate line items for a total of five packages, with delivery required within 20 days after the order. Shipping is designated as FOB Destination to the USNS Impeccable and USS California. All items must be marked according to Medical Marking Standard No. 1 and packaged in suitable sealed containers to prevent damage. The contract mandates compliance with DLA packaging requirements and specifies that shipments must be made via traceable means, explicitly prohibiting the use of parcel post.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-26-T-411U

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

POVIDONE-IODINE TOPICA

Solicitation # SPE2DP-26-T-4848

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4958

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

in 6 days

AI Contract Overview

The Department of National Defence, through its Strategic Medical Countermeasures Program and on behalf of the Canadian Forces Health Services Group, is seeking to procure Pralidoxime. This medication is intended for treating Canadian Armed Forces members who may have been exposed to chemical warfare agents. The contract initially requires the delivery of 1,025 doses by March 31, 2026, with an option to order up to an additional 4,100 doses between April 1, 2026, and March 31, 2030. There are no special security requirements for this procurement. This solicitation is open exclusively to Canadian suppliers and those from applicable trading partners, consistent with the policy on reciprocal procurement. The Crown maintains the right to negotiate with suppliers throughout the procurement process. Interested parties must submit their offers by January 22, 2026. The contract is managed by the Department of National Defence, and the point of contact for this procurement is Stephen Brown. Offers may be submitted in either of Canada’s official languages, and the place of performance is Canada, with worldwide delivery expected.

General Info

Department of National Defence seeks Pralidoxime supply: 1,025 doses by 2026, optional 4,100 doses later.

Agency

Government of Canada → Department of National DefenceView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

*World, CAN

Set-Aside

NONE

Documents

(4)

Amendment 001 to Solicitation W6369-26-A033 Pralidoxime

PDF•2 pages•amendment

Amendment 001 to Solicitation W6369-26-A033 Pralidoxime

PDF•2 pages•amendment

RFP W6369-26-A033 Pralidoxime National Defence Canada

PDF•58 pages•rfp

RFP W6369-26-A033 Pralidoxime

PDF•55 pages•rfp

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJan 22

Solicitation

Response DeadlineJan 22

Deadline has passed

Submission Closed

01/22/2026, 02:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Department of National Defence

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Department of National Defence

View Agency Profile

Office AddressN/A

Contacts

Stephen BrownPoint of Contact

contact@example.gov

+1 (555) 000-0000

Full Description

The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 1,025 doses to be delivered before 31 March 2026. Optional requirements of 4,100 doses to be requested and delivered between 01 April 2026 and 31 March 2030. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.